Log In
Print this Print this

Dupixent, dupilumab (REGN668, SAR231893)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHuman mAb targeting the alpha subunit of the IL-4 receptor (CD124; IL-4RA) and the IL-13 receptor
Molecular Target Interleukin-4 (IL-4) receptor (CD124) (IL-4RA) ; Interleukin-13 (IL-13) receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today